New cell Revelation Offers Hope for type 1 Diabetes Prevention
Table of Contents
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin-a critical hormone that regulates blood sugar in the body. Scientists at Scripps Research recently discovered a new kind of cell that helps protect insulin production, paving the way to understanding how researchers could prevent or reverse type 1 diabetes.
Understanding the Role of VAFs
The new findings,published in Cell reports on 2025/10/09,reveal how vascular-associated fibroblastic cells (VAFs) act as molecular peacekeepers in the pancreas-actively protecting insulin-producing cells from the immune system. This discovery helps explain several puzzling features of type 1 diabetes, including why the disease often has such a long preclinical phase-the symptom-free, early stage of the disease where the immune system is beginning to destroy insulin-producing cells, but blood sugar levels are still normal-and suggests that early intervention could be feasible in the future.
Identifying these VAFs is an exciting step toward a better understanding of how the pancreas interacts with the immune system. This finding unlocks a new understanding of autoimmunity and could help us design better therapeutics for type 1 diabetes and inform how we prevent or reverse the disease.
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research
the Preclinical Phase and Potential Interventions
The extended preclinical phase of type 1 diabetes has long been a mystery. The discovery of VAFs offers a potential description: these cells appear to be actively suppressing the immune attack on insulin-producing cells for a significant period. Understanding how VAFs function and how to bolster their protective capabilities could lead to strategies for delaying or even preventing the onset of the disease.
How VAFs Protect Insulin-producing Cells
Researchers found that VAFs reside near blood vessels in the pancreas and release signaling molecules that dampen the immune response.This localized suppression helps shield insulin-producing cells from immune cell attacks. Further research is needed to identify the specific molecules involved and how their activity can be enhanced.
Future directions and implications
This research opens up new avenues for therapeutic progress. Scientists are now focused on exploring ways to activate or increase the number of VAFs in individuals at risk of developing type 1 diabetes. Potential strategies include developing drugs that stimulate VAF activity or even transplanting VAFs into the pancreas.
Key Takeaways
- Scientists have discovered a new cell type, VAFs, that protect insulin-producing cells from immune attack.
- VAFs help explain the long preclinical phase of type 1 diabetes.
- This discovery suggests that early intervention to bolster VAF activity could prevent or reverse the disease.
- Further research is focused on identifying the specific molecules involved in VAF protection and developing therapeutic strategies.